Leon Wang
Stock Analyst at Barclays
(2.69)
# 1,303
Out of 4,413 analysts
9
Total ratings
50%
Success rate
7.27%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $37 → $40 | $24.72 | +61.81% | 4 | Apr 11, 2024 | |
| RAPT RAPT Therapeutics | Maintains: Overweight | $35 → $13 | $7.70 | +68.83% | 2 | Feb 21, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $40.91 | +44.22% | 3 | Sep 12, 2023 |
Insmed
Apr 11, 2024
Maintains: Overweight
Price Target: $37 → $40
Current: $24.72
Upside: +61.81%
RAPT Therapeutics
Feb 21, 2024
Maintains: Overweight
Price Target: $35 → $13
Current: $7.70
Upside: +68.83%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $40.91
Upside: +44.22%